999 Results
What APA Is Doing for You: Update on Clozapine REMS
In November 2021, the Food and Drug Administration (FDA) instituted a new Clozapine Risk Evaluation and Mitigation Strategy (REMS) to monitor prescribing and dispensing of the drug, which is used to treat schizophrenia. The new REMS led to confusion for manufacturers, pharmacies, prescribers, and patients. Some clinicians stopped prescribing the already underutilized drug, and some pharmacies stopped dispensing it. This chaotic situation led the FDA to stop enforcing certain requirements of the
Attend Cured: The Past, Present, and Future of LGBTQ Rights and the APA
We are excited to bring everyone’s attention to Cured. This documentary chronicles the fight to get homosexuality taken out of the Diagnostic and Statistical Manual as a mental illness.
Philadelphia Inquirer: Shatter the myths about suicide and kids of color
APA CEO and Medical Director, Saul Levin, M.D., M.P.A and APA Department of Diversity and Health Equity Chief, Regina James, M.D. penned an op-ed in the Philadelphia Inquirer, "Shatter the myths about suicide and kids of color."
New Theater, Improv Curriculum Supports DEI Efforts Among Asian American, Native Hawaiian, and Pacific Islander Health Care Trainees
New research presented today at the American Psychiatric Association’s Annual Meeting finds that a new training based in theatre and improv concepts helped empower Asian American, Native Hawaiian, and Pacific Islander (AANHPI) medical students to recognize and respond to racial bias in the clinical setting.
How to Talk About Suicide on Social Media
Social media has tremendous reach and influence. When people post on social media about suicide, that influence can be helpful or hurtful. Conversations about suicide on social media can promote misperceptions and stigma and potentially influence others to attempt suicide
Updates in the Understanding of Autism
April is Autism Acceptance and Awareness Month, dedicated to raising awareness and promoting inclusion for individuals with autism. Once considered a rare condition, autism is now recognized as affecting 2% of the general population. Consequently, the needs of autistic individuals have become a focal point for health care professionals, especially given that those with autism experience psychiatric concerns at significantly higher rates than those without.
New Report Examines Disparities in Dementia Care
A new report from the Alzheimer’s Association finds that non-white racial/ethnic populations expect and experience more barriers when accessing dementia care and report having less trust in medical research than white Americans. “Race, Ethnicity and Alzheimer’s in America,” is a companion report to the Association’s annual Facts and Figures report.
Media Advisory: Media Encouraged to Attend APA Annual Meeting in Philadelphia
The American Psychiatric Association’s 2020 Annual Meeting features nationally recognized experts in psychiatry and mental health policy, research and clinical practice.
Eating Healthy for Brain Health and Staying on Budget
We know that what we eat affects our physical health, but evidence continues to mount that what we eat significantly impacts our mental health also. For example, a healthy diet may be able to help prevent and treat depression, reduce the risk of cognitive impairment and dementia, and help maintain the mental health of children and adolescents.
Texting Patients: Rules of the Road
Using text messaging to communicate with patients can be an easy and effective form of communication for many psychiatrists, and texting is often a preferred form of communication for patients. However, psychiatrists must be aware of relevant rules and regulations before hitting “send.”
The Pandemic and Mental Health
APA Deputy Medical Director and DDHE Chief Dr. Regina James spoke with Howard University's WHUR 96.3 Taking it to the Streets to promote the April 8 Mental Health Equity Fireside Chat.
MEDIA ADVISORY: Innovation Zone: What's Next in Mental Health Technology? American Psychiatric Association Annual Meeting
The American Psychiatric Association (APA) is hosting the 2019 Mental Health Innovation Zone, presented by Takeda Pharmaceuticals, U.S.A., a showcase and catalyst for new mental health technologies, as part of its 2019 Annual Meeting. The Innovation Zone is focused on answering the question: "What is next in mental health technology?" It will include lectures, panel discussions, workshops and a "Shark Tank"-style innovation session where attendees can pitch their own product ideas. Topics will i